Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature

Ann N Y Acad Sci. 2006 Jul:1071:502-7. doi: 10.1196/annals.1364.053.

Abstract

Sleep disturbances are hallmark symptoms of posttraumatic stress disorder (PTSD). Where the subjective experience of nightmares and insomnia in PTSD patients is very real indeed and demands treatment, objective research findings on disordered sleep architecture in PTSD are inconclusive and inconsistent. After reviewing the literature an insufficient number of controlled studies are published to formulate evidence-based guidelines. Several studies have methodological limitations, such as small group sizes and heterogenic samples. Large randomized controlled trials (RCTs) need to be conducted in order to further develop adequate therapeutic interventions. Objective parameters for insomnia and nightmares need to be identified for understanding underlying mechanisms of disturbed sleep in PTSD, and for evaluating therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Anxiety Agents / therapeutic use
  • Anticonvulsants / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Clinical Trials as Topic
  • Dreams / psychology*
  • Humans
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / etiology
  • Stress Disorders, Post-Traumatic / complications
  • Stress Disorders, Post-Traumatic / drug therapy*

Substances

  • Anti-Anxiety Agents
  • Anticonvulsants
  • Antidepressive Agents
  • Antipsychotic Agents